Glenmark Pharmaceutical launches ‘FabiFlu’ for treatment of COVID 19 at 103 per tablet. 1 min read Glenmark Pharmaceutical launches ‘FabiFlu’ for treatment of COVID 19 at 103 per tablet. Saveeta Bajaj June 20, 2020 Glenmark Pharmaceuticals is said to have launched antiviral drug Favipiravir, under the brand name FabiFlu, for the... Read More Read more about Glenmark Pharmaceutical launches ‘FabiFlu’ for treatment of COVID 19 at 103 per tablet.
